← Back

Technology Transfer and Industry News

Wednesday, 25 November 2015

Nanoparticles simplify DNA identification and quantification

In an article published in Small, researchers successfully applied a new qualitative and quantitative method for the detection of a DNA sequence characteristic of Leishmania infantum kinetoplast, a frequent parasite in veterinary that affects humans too. The work was led from the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and the Spin Off company Vetgenomics.

In an article published in Small, researchers successfully applied a new qualitative and quantitative method for the detection of a DNA sequence characteristic of Leishmania infantum kinetoplast, a frequent parasite in veterinary that affects humans too. The work was led from the Catalan Institute of Nanoscience and Nanotechnology (ICN2), a research Centre placed in the Campus of the Autonomous University of Barcelona (UAB) in Bellaterra, and the Spin Off company Vetgenomics.

This work was coordinated at ICN2 by ICREA Prof Arben Merkoci, Leader of the ICN2 Nanobioelectronics & Biosensors Group, and Dr. Alfredo de la Escosura-Muniz (first author of the article) with collaboration of Luis Pires, PhD student from the same group. The work was carried out in collaboration with Prof. Armand Sanchez, Dr. Olga Francino, Dr. Laura Altet and Lorena Serrano from Vetgenomics. Their results are part of the bio-applications defined in the ICN2 Severo Ochoa Program "Devices for Social Challenges". The present work has been published within the POC4PETS European Project (www.poc4pets-fp7.eu), coordinated by the Alma Mater Studiorum - Universita di Bologna (Italy) and aimed to improving the speed and accuracy of current diagnostics for veterinary pathogens. 

Overcoming the classical PCR technique

The Polymerase Chain Reaction (PCR) is today's standard method to identify the presence of a specific DNA sequence in a sample. The PCR uses enzymes and two primers, strands of short nucleic acid sequences that serve as a starting point for DNA copy. When the detection is positive, this technique produces millions of copies of the problem sequence to facilitate its detection. This DNA amplification involves precise thermal changes (thermocycling) and sophisticate and expensive equipment which are overcome by an alternative approach called isothermal amplification, performed at constant temperature.

In this context, the authors of the article present a novel design of isothermal amplification using primers labelled with both gold nanoparticles and magnetic microbeads. The amplified product carries both labels allowing a rapid purification and quantification. The magnetic properties of the first primer facilitate the purification/preconcentration of the amplified DNA through magnetic separation methods. On the other hand, the gold nanoparticles are easily quantified by simple electrocatalytic detection methods. Thus, the use of primers labelled with gold nanoparticles and magnetic microbeads turns isothermal amplification into a faster and easier qualitative and quantitative diagnostic method. 

Nanoparticles for Leishmania detection and other point-of-care tests

This approach was successfully applied for the detection of a DNA sequence characteristic of Leishmania infantum kinetoplast, a parasite responsible of a disease in domestic dogs, wild canids and humans. The electrochemical method exhibited a good reproducibility and sensitivity. Furthermore, amplified DNA from dogs without Leishmania was perfectly discriminated, demonstrating the specificity of both the amplification procedure and the electrochemical detection. In fact, the performance of the proposed approach is better than the obtained with other point-of-care tests for Leishmania detection, offering also a quantitative tool for parasite determination. This method represents a universal methodology that could be applied for any isothermal DNA amplification design.

The technology presented in this article is under patenting process (EP14382266.6/P10398EP00 (09/07/14); PCT/EP2015/065742 (09/07/15)). 

About POC4PETS:

Veterinary diagnostics is a key tool in the prevention and control of infectious diseases in animals. It is increasingly recognized that there is the urgent need for innovation in the animal infectious diseases testing field, bringing to new market applications in the development of specific, rapid and efficiently validated diagnostic tests. The European FP7 project Point of Care Diagnostics for rapid and cheap pathogen detection of companion animals (POC4PETS) aims to apply the most promising new technologies to improving both the speed and accuracy of the current diagnostics for veterinary pathogens of companion animal species.

ICN2's Nanobioelectronics & Biosensors Group, led by ICREA Research Professor Arben Merkoci, is one of the POC4PETS partners. Their research focuses in the development of novel nanotechnology and nanomaterials based sensors for DNA, protein and cells detection. The project is particularly focused in filling the gaps of diagnostics availability and enhancing technology transfer to increase competitiveness of the Veterinary Diagnostic industry.

Vetgenomics (www.vetgenomics.com) is a SME spin-off of the UAB (Universitat Autonoma de Barcelona) founded in 2010 and devoted to molecular diagnostic in companion animals. The research activity is mainly focused in the animal genomics and veterinary genetic diagnostic fields. The main goal is becoming a company focused in innovation and with the flexibility to adapt technology to customer needs, increasing the added value of their products and becoming a partner of choice in R+D+i.

Watch the POC4PETS cartoon presentation video: http://youtu.be/3JPNAtrRt1E

Article reference: Alfredo de la Escosura-Muniz, Luis Baptista-Pires, Lorena Serrano, Laura Altet, Olga Francino, Armand Sanchez, Arben Merkoci. Magnetic bead/gold nanoparticle double-labeled primers for electrochemical detection of isothermal amplified Leishmania DNA. Small. DOI: 10.1002/smll.201502350 http://onlinelibrary.wiley.com/doi/10.1002/smll.201502350/full